Clinical and Mucosal Improvement With Specific Carbohydrate Diet in Pediatric Crohn Disease

Abstract

Clinical and mucosal improvements were seen in children with CD, who used SCD for 12 and 52 weeks. In addition, CE can monitor mucosal improvement in treatment trials for pediatric CD. Further studies are critically needed to understand the mechanisms underlying SCD's effectiveness in children with CD.